Among the clinical parameters that play a pivotal role in predicting the ou
tcome of patients with endometrial carcinoma, intrapeitoneal microscopic di
ssemination represents an important cause of recurrences. To date, peritone
al cytology has been incorporated into the current surgical staging system
(International Federation of Gynecology and Obstetrics 88), although its pr
edictive value remains a controversial issue. In this at;dy the: authors in
vestigated the possibility of applying immunocytochemistry (ICC) to the dia
gnosis of peritoneal washing (PW) aimed at improving conventional cytology
and verifying the prognostic value of peritoneal malignant cells. The autho
rs analyzed 182 PWs sampled from endometrial cancer patients. The ICC analy
sis was performed using two monoclonal antibodies (MAbs)-AR-3 and B72.3-tha
t in combination recognize more than 95% of endometrial carcinomas. The pre
sence of peritoneal-free cancer cells was identified morphologically in 27
of 182 lavages (14.8%) and ICC in 50 of 182 (27.5%), with a significant imp
rovement (p <0.0001). Five-year survival analysis, comparing results of ICC
and cytodiagnosis, demonstrated a significant decrease of disease-free sur
vival in patients with peritoneal microscopic disease. Furthermore, multiva
riate analysis showed that ICC diagnosis of PWs is an independent prognosti
c factor. Data indicate that the use of selected MAbs allows one to identif
y cytologically false-negative cases, providing results that are highly pre
dictive of a worse clinical outcome.